Click for best price
COVID19 Drugs Market Size, Share 2023
This report contains market size and forecasts of COVID-19 Drugs in Global, including the following market information:
Global COVID-19 Drugs Market Size 2024-2035, ($ millions)
The global COVID-19 Drugs market is projected to reach US$ million by 2035.
We surveyed the COVID-19 Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global COVID-19 Drugs Market, by Type, 2024-2035 ($ millions)
Global COVID-19 Drugs Market Segment Percentages, by Type
Tablet
Injection
Global COVID-19 Drugs Market, by Application, 2024-2035 ($ millions)
Global COVID-19 Drugs Market Segment Percentages, by Application
Mild Symptom Patient
Critically Ill Patient
Global COVID-19 Drugs Market, By Region and Country, 2024-2035 ($ Millions)
Global COVID-19 Drugs Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Novartis
Shanghai Zhongxisanwei
Teva
Zydus Cadila
Mylan
Apotex
Advanz Pharma
Sun Pharma
Kyung Poong
Ipca Laboratories
Hanlim Pharmaceutical
Bristol Laboratories
Bayer
Rising Pharmaceutical
Shanghai Pharma
Sichuan Sunny Hope
Guangzhou Baiyunshan Guanghua Pharmaceutical
CSPC Group
KPC Group
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
| Report Attributes |
Report Details |
| Report Title |
COVID-19 Drugs Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
103 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 COVID-19 Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 Drugs Overall Market Size
2.1 Global COVID-19 Drugs Market Size: 2023 VS 2035
2.2 Global COVID-19 Drugs Market Size, Prospects & Forecasts: 2023-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 Drugs Players in Global Market
3.2 Global Companies COVID-19 Drugs Product & Technology
4 COVID-19 Drugs Companies Profiles
4.1 Sanofi
4.1.1 Sanofi Company Summary
4.1.2 Sanofi Business Overview
4.1.3 Sanofi COVID-19 Drugs Product Offerings & Technology
4.1.4 Sanofi COVID-19 Drugs R&D, and Plans
4.2 Novartis
4.2.1 Novartis Company Summary
4.2.2 Novartis Business Overview
4.2.3 Novartis COVID-19 Drugs Product Offerings & Technology
4.2.4 Novartis COVID-19 Drugs R&D, and Plans
4.3 Shanghai Zhongxisanwei
4.3.1 Shanghai Zhongxisanwei Company Summary
4.3.2 Shanghai Zhongxisanwei Business Overview
4.3.3 Shanghai Zhongxisanwei COVID-19 Drugs Product Offerings & Technology
4.3.4 Shanghai Zhongxisanwei COVID-19 Drugs R&D, and Plans
4.4 Teva
4.4.1 Teva Company Summary
4.4.2 Teva Business Overview
4.4.3 Teva COVID-19 Drugs Product Offerings & Technology
4.4.4 Teva COVID-19 Drugs R&D, and Plans
4.5 Zydus Cadila
4.5.1 Zydus Cadila Company Summary
4.5.2 Zydus Cadila Business Overview
4.5.3 Zydus Cadila COVID-19 Drugs Product Offerings & Technology
4.5.4 Zydus Cadila COVID-19 Drugs R&D, and Plans
4.6 Mylan
4.6.1 Mylan Company Summary
4.6.2 Mylan Business Overview
4.6.3 Mylan COVID-19 Drugs Product Offerings & Technology
4.6.4 Mylan COVID-19 Drugs R&D, and Plans
4.7 Apotex
4.7.1 Apotex Company Summary
4.7.2 Apotex Business Overview
4.7.3 Apotex COVID-19 Drugs Product Offerings & Technology
4.7.4 Apotex COVID-19 Drugs R&D, and Plans
4.8 Advanz Pharma
4.8.1 Advanz Pharma Company Summary
4.8.2 Advanz Pharma Business Overview
4.8.3 Advanz Pharma COVID-19 Drugs Product Offerings & Technology
4.8.4 Advanz Pharma COVID-19 Drugs R&D, and Plans
4.9 Sun Pharma
4.9.1 Sun Pharma Company Summary
4.9.2 Sun Pharma Business Overview
4.9.3 Sun Pharma COVID-19 Drugs Product Offerings & Technology
4.9.4 Sun Pharma COVID-19 Drugs R&D, and Plans
4.10 Kyung Poong
4.10.1 Kyung Poong Company Summary
4.10.2 Kyung Poong Business Overview
4.10.3 Kyung Poong COVID-19 Drugs Product Offerings & Technology
4.10.4 Kyung Poong COVID-19 Drugs R&D, and Plans
4.11 Ipca Laboratories
4.11.1 Ipca Laboratories Company Summary
4.11.2 Ipca Laboratories Business Overview
4.11.3 Ipca Laboratories COVID-19 Drugs Product Offerings & Technology
4.11.4 Ipca Laboratories COVID-19 Drugs R&D, and Plans
4.12 Hanlim Pharmaceutical
4.12.1 Hanlim Pharmaceutical Company Summary
4.12.2 Hanlim Pharmaceutical Business Overview
4.12.3 Hanlim Pharmaceutical COVID-19 Drugs Product Offerings & Technology
4.12.4 Hanlim Pharmaceutical COVID-19 Drugs R&D, and Plans
4.13 Bristol Laboratories
4.13.1 Bristol Laboratories Company Summary
4.13.2 Bristol Laboratories Business Overview
4.13.3 Bristol Laboratories COVID-19 Drugs Product Offerings & Technology
4.13.4 Bristol Laboratories COVID-19 Drugs R&D, and Plans
4.14 Bayer
4.14.1 Bayer Company Summary
4.14.2 Bayer Business Overview
4.14.3 Bayer COVID-19 Drugs Product Offerings & Technology
4.14.4 Bayer COVID-19 Drugs R&D, and Plans
4.15 Rising Pharmaceutical
4.15.1 Rising Pharmaceutical Company Summary
4.15.2 Rising Pharmaceutical Business Overview
4.15.3 Rising Pharmaceutical COVID-19 Drugs Product Offerings & Technology
4.15.4 Rising Pharmaceutical COVID-19 Drugs R&D, and Plans
4.16 Shanghai Pharma
4.16.1 Shanghai Pharma Company Summary
4.16.2 Shanghai Pharma Business Overview
4.16.3 Shanghai Pharma COVID-19 Drugs Product Offerings & Technology
4.16.4 Shanghai Pharma COVID-19 Drugs R&D, and Plans
4.17 Sichuan Sunny Hope
4.17.1 Sichuan Sunny Hope Company Summary
4.17.2 Sichuan Sunny Hope Business Overview
4.17.3 Sichuan Sunny Hope COVID-19 Drugs Product Offerings & Technology
4.17.4 Sichuan Sunny Hope COVID-19 Drugs R&D, and Plans
4.18 Guangzhou Baiyunshan Guanghua Pharmaceutical
4.18.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Company Summary
4.18.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Business Overview
4.18.3 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product Offerings & Technology
4.18.4 Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs R&D, and Plans
4.19 CSPC Group
4.19.1 CSPC Group Company Summary
4.19.2 CSPC Group Business Overview
4.19.3 CSPC Group COVID-19 Drugs Product Offerings & Technology
4.19.4 CSPC Group COVID-19 Drugs R&D, and Plans
4.20 KPC Group
4.20.1 KPC Group Company Summary
4.20.2 KPC Group Business Overview
4.20.3 KPC Group COVID-19 Drugs Product Offerings & Technology
4.20.4 KPC Group COVID-19 Drugs R&D, and Plans
4.21 Jinghua Pharmaceutical Group
4.21.1 Jinghua Pharmaceutical Group Company Summary
4.21.2 Jinghua Pharmaceutical Group Business Overview
4.21.3 Jinghua Pharmaceutical Group COVID-19 Drugs Product Offerings & Technology
4.21.4 Jinghua Pharmaceutical Group COVID-19 Drugs R&D, and Plans
4.22 Zhongsheng Pharma
4.22.1 Zhongsheng Pharma Company Summary
4.22.2 Zhongsheng Pharma Business Overview
4.22.3 Zhongsheng Pharma COVID-19 Drugs Product Offerings & Technology
4.22.4 Zhongsheng Pharma COVID-19 Drugs R&D, and Plans
4.23 North China Pharmaceutical Group
4.23.1 North China Pharmaceutical Group Company Summary
4.23.2 North China Pharmaceutical Group Business Overview
4.23.3 North China Pharmaceutical Group COVID-19 Drugs Product Offerings & Technology
4.23.4 North China Pharmaceutical Group COVID-19 Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 Drugs Market Size, 2024 & 2035
5.2 By Region - Global COVID-19 Drugs Revenue, (2024-2035)
5.3 United States
5.3.1 Key Players of COVID-19 Drugs in United States
5.3.2 United States COVID-19 Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 Drugs in Europe
5.4.2 Europe COVID-19 Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 Drugs in China
5.5.2 China COVID-19 Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global COVID-19 Drugs Market Size Markets, 2024 & 2035
6.2 Tablet
6.3 Injection
7 Sights by Application
7.1 By Application - Global COVID-19 Drugs Market Size, 2024 & 2035
7.2 Mild Symptom Patient
7.3 Critically Ill Patient
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. COVID-19 Drugs Market Opportunities & Trends in Global Market
Table 2. COVID-19 Drugs Market Drivers in Global Market
Table 3. COVID-19 Drugs Market Restraints in Global Market
Table 4. Key Players of COVID-19 Drugs in Global Market
Table 5. Global Companies COVID-19 Drugs Product & Technology
Table 6. Sanofi Company Summary
Table 7. Sanofi COVID-19 Drugs Product Offerings
Table 8. Novartis Company Summary
Table 9. Novartis COVID-19 Drugs Product Offerings
Table 10. Shanghai Zhongxisanwei Company Summary
Table 11. Shanghai Zhongxisanwei COVID-19 Drugs Product Offerings
Table 12. Teva Company Summary
Table 13. Teva COVID-19 Drugs Product Offerings
Table 14. Zydus Cadila Company Summary
Table 15. Zydus Cadila COVID-19 Drugs Product Offerings
Table 16. Mylan Company Summary
Table 17. Mylan COVID-19 Drugs Product Offerings
Table 18. Apotex Company Summary
Table 19. Apotex COVID-19 Drugs Product Offerings
Table 20. Advanz Pharma Company Summary
Table 21. Advanz Pharma COVID-19 Drugs Product Offerings
Table 22. Sun Pharma Company Summary
Table 23. Sun Pharma COVID-19 Drugs Product Offerings
Table 24. Kyung Poong Company Summary
Table 25. Kyung Poong COVID-19 Drugs Product Offerings
Table 26. Ipca Laboratories Company Summary
Table 27. Ipca Laboratories COVID-19 Drugs Product Offerings
Table 28. Hanlim Pharmaceutical Company Summary
Table 29. Hanlim Pharmaceutical COVID-19 Drugs Product Offerings
Table 30. Bristol Laboratories Company Summary
Table 31. Bristol Laboratories COVID-19 Drugs Product Offerings
Table 32. Bayer Company Summary
Table 33. Bayer COVID-19 Drugs Product Offerings
Table 34. Rising Pharmaceutical Company Summary
Table 35. Rising Pharmaceutical COVID-19 Drugs Product Offerings
Table 36. Shanghai Pharma Company Summary
Table 37. Shanghai Pharma COVID-19 Drugs Product Offerings
Table 38. Sichuan Sunny Hope Company Summary
Table 39. Sichuan Sunny Hope COVID-19 Drugs Product Offerings
Table 40. Guangzhou Baiyunshan Guanghua Pharmaceutical Company Summary
Table 41. Guangzhou Baiyunshan Guanghua Pharmaceutical COVID-19 Drugs Product Offerings
Table 42. CSPC Group Company Summary
Table 43. CSPC Group COVID-19 Drugs Product Offerings
Table 44. KPC Group Company Summary
Table 45. KPC Group COVID-19 Drugs Product Offerings
Table 46. Jinghua Pharmaceutical Group Company Summary
Table 47. Jinghua Pharmaceutical Group COVID-19 Drugs Product Offerings
Table 48. Zhongsheng Pharma Company Summary
Table 49. Zhongsheng Pharma COVID-19 Drugs Product Offerings
Table 50. North China Pharmaceutical Group Company Summary
Table 51. North China Pharmaceutical Group COVID-19 Drugs Product Offerings
Table 52. By Region? Global COVID-19 Drugs Revenue, (US$, Mn), 2024 & 2035
Table 53. By Region - Global COVID-19 Drugs Revenue, (US$, Mn), 2024-2035
Table 54. By Type ? Global COVID-19 Drugs Market Size, (US$, Mn), 2024 & 2035
Table 55. By Application? Global COVID-19 Drugs Market Size, (US$, Mn), 2024 & 2035
List of Figures
Figure 1. COVID-19 Drugs Segment by Type in 2035
Figure 2. COVID-19 Drugs Segment by Application in 2035
Figure 3. Global COVID-19 Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 Drugs Market Size: 2023 VS 2035 (US$, Mn)
Figure 6. Global COVID-19 Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 Drugs Revenue Market Share, 2024-2035
Figure 8. By Type - Global COVID-19 Drugs Revenue Market Share, 2024-2035
Figure 9. By Application - Global COVID-19 Drugs Revenue Market Share, 2024-2035
